Approximately 20% of breast cancers overexpress the membrane tyrosine kinase, human epidermal growth factor receptor 2 (HER2), leading to uncontrolled cell proliferation and survival through increased receptor dimerization. This evidence concerns the gene ERBB2 and breast cancer.